earnings
LE
NASDAQ · LENZ
LENZ Therapeutics, Inc.
Healthcare · Biotechnology
$4.23
Down-$0.24 (-5.37%)
Updated Sep 16, 2026, 1:15 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 684.09M
- P/E ratio
- -13.13
- Dividend yield
- 0.00%
- 52-week range
- $4.42 – $50.40
- Volume
- 819.74K
- Avg. volume
- 997.98K
Price performance
LENZ price history
1M range · 20 trading sessions · Daily adjusted prices
LENZ closed at $4.23 after 20 trading sessions, down 11.32% for the selected period.
- Last close
- $4.23
- Period change
- -11.32%
- Period low
- $4.23
- Period high
- $5.96
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $4.44 | $4.44 | $4.205 | $4.23 | 819.74K |
| Sep 14, 2026 | $4.53 | $4.60 | $4.42 | $4.47 | 744.34K |
| Sep 11, 2026 | $4.71 | $4.77 | $4.50 | $4.52 | 978.25K |
| Sep 10, 2026 | $4.85 | $4.88 | $4.68 | $4.72 | 569.05K |
| Sep 9, 2026 | $5.31 | $5.405 | $4.885 | $4.91 | 705.8K |
| Sep 8, 2026 | $5.95 | $5.95 | $5.32 | $5.33 | 642.87K |
| Sep 4, 2026 | $5.75 | $5.98 | $5.615 | $5.96 | 488.96K |
| Sep 3, 2026 | $5.90 | $5.97 | $5.65 | $5.83 | 835.14K |
| Sep 2, 2026 | $5.21 | $5.81 | $5.21 | $5.80 | 993.29K |
| Sep 1, 2026 | $5.17 | $5.305 | $5.00 | $5.23 | 605.58K |
| Aug 31, 2026 | $5.06 | $5.275 | $5.008 | $5.21 | 713.74K |
| Aug 28, 2026 | $4.80 | $5.13 | $4.69 | $5.11 | 680.21K |
| Aug 27, 2026 | $4.78 | $4.8328 | $4.7182 | $4.81 | 439.22K |
| Aug 26, 2026 | $4.67 | $4.84 | $4.58 | $4.78 | 546.04K |
| Aug 25, 2026 | $4.58 | $4.81 | $4.58 | $4.67 | 542.23K |
| Aug 24, 2026 | $4.65 | $4.70 | $4.5467 | $4.59 | 497.91K |
| Aug 21, 2026 | $4.71 | $4.81 | $4.67 | $4.68 | 475.32K |
| Aug 20, 2026 | $4.88 | $4.90 | $4.575 | $4.66 | 567.53K |
| Aug 19, 2026 | $4.82 | $5.036 | $4.81 | $4.92 | 583.51K |
| Aug 18, 2026 | $4.77 | $4.89 | $4.74 | $4.77 | 534.41K |
Latest LENZ news
The latest Smart Investors Daily articles mentioning LENZ.
Stock researchMarket Activity · Short Interest
Loading stock research…